| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.67 | 0.05 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.34 | 0.06 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.33 | 0.07 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.27 | 4e-08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.26 | 5e-08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.26 | 5e-06 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.26 | 1e-11 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.26 | 8e-07 |